Semaglutide GLP-1 pathway Semaglutide is a GLP-1 receptor agonist already FDA-approved for chronic weight management as Wegovy (2.4 mg) and for type 2 diabetes as Ozempic
Our platform helps you determine optimal 10-day vs 20-day protocols, cycling frequency for your needs, and whether maintenance dosing makes sense
It gets injected under the skin, reaches cells quickly, inhibits NNMT (overactive in fat tissue), preserves more NAD+ for energy production, reduces fat storage, and encourages the body to burn fat as fuel
Its already a popular ingredient in topical skin and haircare products, with manufacturers claiming it can do everything from reducing fine lines and fading hyperpigmentation to tightening loose skin
Trouble focusing, memory lapses, and a general mental haze are common neurological symptoms of low B12